A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

Document type :
Conference papers
Complete list of metadatas

https://hal.univ-brest.fr/hal-02150798
Contributor : Geneviève Michel <>
Submitted on : Friday, June 7, 2019 - 2:34:54 PM
Last modification on : Sunday, June 9, 2019 - 1:17:26 AM

Identifiers

  • HAL Id : hal-02150798, version 1

Citation

Maria Juárez, Nieves Diaz, Geoffrey I Johnston, Saba Nayar, Andrew Payne, et al.. A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02150798⟩

Share

Metrics

Record views

18